Leveraging Virtual Care Strategies to Improve Access and Treatment for Individuals With Alcohol Use Disorders
Launched by UNIVERSITY OF MICHIGAN · Oct 21, 2022
Trial Information
Current as of May 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how technology can help people who struggle with alcohol use disorders. Researchers want to find out if using online programs can make it easier for individuals to manage their health and behaviors related to alcohol. The programs will focus on understanding what is important to participants, setting health goals, and learning new skills to handle their alcohol use and overall well-being. This study aims to discover effective ways to provide health information that is both useful and engaging.
To participate in this study, individuals must be between the ages of 18 and 65 and have a history of heavy alcohol use in the past month. They should also have access to the internet and a phone, and be able to give their consent to participate. Participants can expect to engage with technology-driven tools designed to support their health journey. It's important to note that those currently receiving treatment for alcohol use or involved in other similar studies may not be eligible. This trial is a great opportunity for those looking for new ways to manage their alcohol use and improve their health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • AUD
- • past month heavy alcohol use
- • internet access
- • phone access
- • able to provide informed consent
- Exclusion Criteria:
- • inability to speak or understand English
- • conditions precluding informed consent or understanding of intervention or assessment content
- • recent AUD treatment
- • history of or at risk for complex alcohol withdrawal
- • involvement in another ongoing study for alcohol/mental health/substance use treatment
- • current cancer diagnosis/ currently receiving cancer treatment (other than skin cancers)
- • PI discretion
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Erin E Bonar
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials